We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation

This study has been terminated.
(The clinical use of Campath for transplant patients was temporarily suspended.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00177138
First Posted: September 15, 2005
Last Update Posted: February 7, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Bayer
Gruessner, Rainer, MD
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2006
  Primary Completion Date: No date given